Market Place
Sourcing Support
Eureka Announces UCSF Benioff Children’s Hospitals for ARYA-2 Clinical Trial
02 Apr 2024 //
BUSINESSWIRE
Eureka Advances PII for Treatment of Liver Cancer Using GPC3-Targeting
18 Mar 2024 //
BUSINESSWIRE
Eureka Awarded $10.6 Million CIRM Grant to Support Clinical Trial of ARTEMIS
06 Jun 2023 //
BUSINESSWIRE
Eureka Licenses Antibody Targeting Mesothelin from National Cancer Institute
14 Mar 2023 //
BUSINESSWIRE
Eureka Announces License with the NCI for GPC2 ARTEMIS T Cell Therapy
18 Oct 2022 //
BUSINESSWIRE
Eureka Receives Orphan Drug Designations for Treatment of Hepatoblastoma
17 Oct 2022 //
BUSINESSWIRE
SPAC on track: Estrella Biopharma signs deal with TradeUP
03 Oct 2022 //
FIERCEBIOTECH
Eureka Announces New England Journal of Medicine Publication of Study of GPRC5D
28 Sep 2022 //
BUSINESSWIRE
Eureka Announces Publication of Crystal Structure of TCR Mimic
03 Aug 2022 //
BUSINESSWIRE
Eureka Tx Announces Publication of Study Demonstrating Broad Anti-Tumor Activity
06 Jun 2022 //
BUSINESSWIRE
Eureka Tx, City of Hope Treat First Patient with GPC3 Targeting ARTEMIS T Cells
31 May 2022 //
BUSINESSWIRE
Eureka Therapeutics to Present at the 18th Annual PEGS Boston Conference & Expo
25 Apr 2022 //
BUSINESSWIRE
Eureka Tx Receives ODD for Hepatocellular Carcinoma With ARTEMIS T Cells
08 Feb 2022 //
BUSINESSWIRE
Eureka Initiates Phase I/II ARYA-2 Trial of ET140203 ARTEMIS T Cells
17 Nov 2021 //
BUSINESSWIRE
Imugene, Eureka Collaborate to Advance Oncolytic Virus and T-Cell Therapy
01 Nov 2021 //
BUSINESSWIRE
Chutes & Ladders—Pfizer`s development leader is retiring in early 2022
08 Oct 2021 //
FIERCEBIOTECH
Eureka Announces Initiation of Phase I/II ARYA-3 Clinical Trial of ARTEMIS®
21 Jul 2021 //
BUSINESSWIRE
ACB hires Liu from Eureka Therapeutics to lead push into clinic
14 Jul 2021 //
FIERCEBIOTECH
Eureka Therapeutics Announces Successful Preclinical Results of InvisiMask™
14 Dec 2020 //
BUSINESSWIRE
Eureka Therapeutics Announces Successful Preclinical Results of InvisiMask™
14 Dec 2020 //
BUSINESSWIRE
COVID-19 nasal spray from Eureka protects mice against infection
14 Dec 2020 //
FIERCEBIOTECH
Eureka Therapeutics Appoints Nobel Laureate Randy Schekman, Ph.D
09 Nov 2020 //
BIOSPACE
Eureka Announces Initiation of ARYA-1 Clinical Trial to Evaluate ET140203
05 Oct 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.